Tackling depression in cancer patients can extend life
Key points
- A study recommended by David Spiegel of Faculty of 1000 Medicine, looks at the relationship between depression care management and survival rates in older patients.
- The better survival rates were not seen in patients with depression and cardiovascular disease, only in those with cancer.
- He concludes, “Vigorous diagnosis and treatment programs for comorbid depression in cancer patients should, based on this study, extend survival time.”
- 2 The effect of a primary care practice-based depression intervention on mortality in older adults: a randomized trial.
A study recommended by David Spiegel of Faculty of 1000 Medicine, looks at the relationship between depression care management and survival rates in older patients. He identifies it as “an important and well-conducted study of the effects of treatment of depression on survival in a primary care setting”
A leading authority on mind-body interactions and professor of psychiatry and behavioural sciences at Stanford University, Spiegel evaluates the research published in the Annals of Internal Medicine, stressing the finding that “Comorbid depression shortens survival time with cancer, and intervention with medication and psychotherapy can therefore extend survival among cancer patients.”
The better survival rates were not seen in patients with depression and cardiovascular disease, only in those with cancer. Spiegel notes that this “is surprising given the well-known link between depression and poor cardiovascular disease outcome”.
He concludes, “Vigorous diagnosis and treatment programs for comorbid depression in cancer patients should, based on this study, extend survival time.”
###
Notes to Editors
1 Dr. David Spiegel, Faculty Member for F1000 Medicine Psychiatry Specialty, is a global authority on mind-body interactions and professor of psychiatry and behavioural sciences at Stanford University
2 The effect of a primary care practice-based depression intervention on mortality in older adults: a randomized trial.
Gallo JJ, Bogner HR, Morales KH, Post EP, Lin JY, Bruce ML
Ann Intern Med 2007 May 15 146(10):689-98
Please name Faculty of 1000 Medicine in any story you write. If you are writing for the web, please link to the website.
4 Faculty of 1000 Medicine, www. f1000medicine.com, is a unique online service that helps clinicians and researchers stay informed of high impact articles and access the opinions of global leaders in medicine. A distinguished international faculty select and evaluate key articles across medicine, providing a rapidly updated, authoritative guide to the medical literature that matters.
5 Please contact Jemima Tonks for a complimentary journalist subscription to Faculty of 1000 Medicine.
Contact: Jemima Tonks
[email protected]
44-020-763-19933
BioMed Central
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Mental Health →
NewsDepression and inflammation linked to pain in rheumatoid arthritis patients
Rheumatoid Arthritis (RA) is a chronic autoimmune disease that causes inflammation of the joints and surrounding tissues. More than 1.3 million adults in the U.S. suffer from RA with 75% of those afflicted being women.…
5 August 2009
GuideIncidence and Prevalence of Depression in Patients With Schizophrenia
More than two dozen studies have been published examining the rates of occurrence of depression in the course of schizophrenia (Koreen et al. 1993; Sands and Harrow 1999; Siris 1991, 1995; Tapp et al. 1994). They have…
16 June 2009
NewsDepression in heart patients ups heart failure risk
Patients who develop coronary artery disease and are subsequently diagnosed with depression have an increased risk of heart failure, even if they are taking antidepressant medication, according to findings from the…
